Cell therapy in surgical treatment of fistulas. Preliminary results

Journal Title: Polish Journal of Surgery - Year 2017, Vol 89, Issue 3

Abstract

Risk of recurrence after surgical treatment of a recurrent fistula is up to 50%. It has be known that more aggressive surgical treatment is associated with a high risk of anal sphincter damage and leads to incontinence. Several studies have been designed to elaborate minimally invasive treatment of rectovaginal and anal fistulas. The properties of Adipose-derived Stem Cells (ASC) significantly enhance a natural healing potency. Here, we present our experience with combined surgical and cell therapy in the treatment of fistulas. Materials and Methods: Four patients were enrolled in our study after unsuccessful treatments in the past – patients 1-3 with rectovaginal fistulas including two women after graciloplasty, and patient 4 - a male with complex perianal fistula. Adipose tissue was obtained from subcutaneous tissue. ASCs were isolated, cultured up to 10+/-2 mln cells and injected into the walls of fistulas. Follow-up physical examination and anoscopy were performed at 1, 4, 8, and 12 weeks, 6 and 12 months after implantation. Results: Up to 8 weeks after ASC implantation, symptoms of fistulas’ tracts disappeared. At 8 weeks, in patients 1-3, communication between vaginal and rectal openings was closed and at 12-16 w. intestinal continuity was restored in patient 3 and 4. After a 6-month follow-up, the fistula tract of patient 4 was closed. Up to 12 m. after ASC implantation no recurrences or adverse events were observed. Conclusion: ASCs combined with surgical pre-treated fistula tracts were used in four patients. All of them were healed. This encouraging result needs further trials to evaluate the clinical efficiency and the cost-effectiveness ratio.<br/><br/>

Authors and Affiliations

Marcin Piejko, Michał Romaniszyn, Julia Borowczyk-Michałowska, Justyna Drukała, Piotr Wałęga

Keywords

Related Articles

Penetrating trauma to the facial skeleton by pickaxe – case report

Number of deaths related with injuries suffered as a result of experienced traumas is increasing. Penetrating traumas of the facial skeleton occur relatively rarely and much more often concern rather children than adults...

Guzy torbielowate trzustki: leczenie chirurgiczne

Celem niniejszego badania było dokonanie oceny krótkoterminowych wyników leczenia chirurgicznego guzów torbielowatych trzustki. Materiał i metody: Dokonaliśmy retrospektywnej oceny dokumentacji medycznej 46 pacjentów (31...

Overtreatment in surgery – does it concern also the patients with ductal breast carcinoma in situ

Overtreatment means treatment that goes beyond current standards, and patients with any disease can be overtreated. Overtreatment is also given to patients with cancer, including those who need surgery. Overtreatment is...

Gruczolakotorbielak śluzowy wyrostka robaczkowego – opis przypadku

Nowotwory wyrostka robaczkowego należą do rzadkości i stanowią ok. 0,4% nowotworów przewodu pokarmowego. Wśród nich najczęściej występującym nowotworem łagodnym jest gruczolakotorbielak śluzowy. Występuje w 0,6% resekowa...

Localized Control of Exsanguinating Arterial Hemorrhage: An Experimental Model

To develop an arterial injury model for testing hemostatic devices at well-defined high and low bleeding rates. <br/><b>Material and method.</b> A side-hole arterial injury was created in the carotid artery of sheep. Sh...

Download PDF file
  • EP ID EP189643
  • DOI 10.5604/01.3001.0010.1019
  • Views 91
  • Downloads 0

How To Cite

Marcin Piejko, Michał Romaniszyn, Julia Borowczyk-Michałowska, Justyna Drukała, Piotr Wałęga (2017). Cell therapy in surgical treatment of fistulas. Preliminary results. Polish Journal of Surgery, 89(3), 48-51. https://europub.co.uk/articles/-A-189643